InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 09/08/2020 10:31:23 AM

Tuesday, September 08, 2020 10:31:23 AM

Post# of 2118
BREAKING NEWS: $ALBO Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC

-Highly statistically significant reductions in both pruritus and serum bile acids- -Well tolerated with very low incidence of diarrhea- -Similar efficacy in children with PFIC1 or PFIC2- -Pivotal trial results substantiate potential for odevixibat to be first drug for PFIC pa...

Read the whole news ALBO - Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC